Volume 20, Issue 10 (October 2022)                   IJRM 2022, 20(10): 873-882 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sutrisno S, Miryani I, Dwijayasa P M, Suprobo N R, Wiyasa I W A. Genistein administration increases the level of superoxide dismutase and glutathione peroxidase in the endometriosis mice model: An experimental study. IJRM 2022; 20 (10) :873-882
URL: http://ijrm.ssu.ac.ir/article-1-2376-en.html
1- Department of Obstetrics and Gynecology, Faculty of Medicine, Brawijaya University/Saiful Anwar General Hospital, Malang, East Java, Indonesia. Department of Midwifery, Faculty of Medicine, Brawijaya University, Malang, East Java, Indonesia.
2- Department of Obstetrics and Gynecology, Faculty of Medicine, Brawijaya University/Saiful Anwar General Hospital, Malang, East Java, Indonesia.
3- Department of Public Health, Faculty of Sport Science, Universitas Negeri Malang, Malang, Indonesia. , suprobonina@gmail.com
Abstract:   (307 Views)
Background: Endometriosis and infertility are caused by reactive oxygen species or free radicals, which promote endometrial cell growth and adhesion in the peritoneal cavity. Genistein has been proven to protect cells against reactive oxygen species by scavenging free radicals and decreasing the expression of genes-associated stress responses.
Objective: This study was conducted to determine whether genistein also acts as an antioxidant by elevating superoxide dismutase (SOD) and glutathione peroxidase (GPx) in the peritoneal fluid of the endometriosis mice model.
Materials and Methods: This experimental study involved 32 healthy female mice (Mus musculus), aged between 2-3 months and weighing 20-30 gr. They were divided into negative control group (healthy mice without genistein), endometriosis group (endometriosis mice without genistein), treatment group that was given different doses of genistein, that is, 0.13; 0.26; 0.52; 0.78; 1.04; and 1.3 mg/day (n = 4/each). SOD level in the peritoneal fluid was measured using the quantitative colorimetric determination method, and a colorimetric assay measured the GPx levels.
Results: Results showed that the endometriosis model has lower SOD and GPx levels than the control group. The administration of genistein significantly normalized these changes. Genistein significantly increased SOD levels in the 0.13 mg and 0.26 mg treatment groups. Genistein also increased GPx levels significantly in all treatment groups.
Conclusion: Genistein increases SOD and GPx levels in the peritoneal fluid of an endometriosis mice model, and the change is dose-dependent.
Full-Text [PDF 526 kb]   (218 Downloads) |   |   Full-Text (HTML)  (9 Views)  
Type of Study: Original Article | Subject: Fertility & Infertility

References
1. Taylor HS, Pal L, Sell E, Kodaman P. Speroff's clinical gynecologic endocrinology and infertility. 9th Ed. Philadelphia: Lippincott Williams & Wilkins; 2019.
2. Ekarattanawong S, Tanprasertkul Ch, Somprasit Ch, Chamod Ph, Tiengtip R, Bhamarapravatana K, et al. Possibility of using superoxide dismutase and glutathione peroxidase as endometriosis biomarkers. Int J Womens Health 2017; 9: 711-716. [DOI:10.2147/IJWH.S141021] [PMID] [PMCID]
3. Iwabuchi T, Yoshimoto Ch, Shigetomi H, Kobayashi H. Oxidative stress and antioxidant defense in endometriosis and its malignant transformation. Oxid Med Cell Longev 2015; 2015: 848595. [DOI:10.1155/2015/848595] [PMID] [PMCID]
4. Kobayashi H, Imanaka S, Nakamura H, Tsuji A. Understanding the role of epigenomic, genomic and genetic alterations in the development of endometriosis (review). Mol Med Rep 2014; 9: 1483-1505. [DOI:10.3892/mmr.2014.2057] [PMID]
5. Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr Biol 2014; 24: R453-462. [DOI:10.1016/j.cub.2014.03.034] [PMID] [PMCID]
6. Carillon J, Rouanet JM, Cristol JP, Brion R. Superoxide dismutase administration, a potential therapy against oxidative stress related diseases: Several routes of supplementation and proposal of an original mechanism of action. Pharm Res 2013; 30: 2718-2728. [DOI:10.1007/s11095-013-1113-5] [PMID]
7. Elnashar A. Emerging treatment of endometriosis. Middle East Fertil Soc J 2015; 20: 61-69. [DOI:10.1016/j.mefs.2014.12.002]
8. Taniguchi F, Harada T. Endometriosis in experimental models. In: Harada T. Endometriosis: Pathogenesis and treatment. 1st Ed. Tokyo: Springer; 2014. [DOI:10.1007/978-4-431-54421-0_14]
9. Deachapunya C, Poonyachoti S. Activation of chloride secretion by isoflavone genistein in endometrial epithelial cells. Cell Physiol Biochem 2013; 32: 1473-1486. [DOI:10.1159/000356584] [PMID]
10. Rajaei S, Alihemmati A, Abedelahi A. Antioxidant effect of genistein on ovarian tissue morphology, oxidant and antioxidant activity in rats with induced polycystic ovary syndrome. Int J Reprod BioMed 2019; 17: 11-22. [DOI:10.18502/ijrm.v17i1.3816] [PMID] [PMCID]
11. Kumar A, Khushboo K, Pandey R, Sharma B. Modulation of superoxide dismutase activity by mercury, lead, and arsenic. Biol Trace Elem Res 2020; 196: 654-661. [DOI:10.1007/s12011-019-01957-3] [PMID]
12. Pocernich ChB, Butterfield DA. Elevation of glutathione as a therapeutic strategy in Alzheimer disease. Biochim Biophys Acta 2012; 1822: 625-630. [DOI:10.1016/j.bbadis.2011.10.003] [PMID] [PMCID]
13. Ighodaro OM, Akinloye OA. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid. Alexandria J Med 2018; 54: 287-293. [DOI:10.1016/j.ajme.2017.09.001]
14. Pizzino G, Irrera N, Cucinotta M, Pallio G, Mannino F, Arcoraci V, et al. Oxidative stress: Harms and benefits for human health. Oxid Med Cell Longev 2017; 2017: 8416763. [DOI:10.1155/2017/8416763] [PMID] [PMCID]
15. Yener NA, Sinanoglu O, Ilter E, Celik A, Sezgin G, Midi A, et al. Effects of spirulina on cyclophosphamide-induced ovarian toxicity in rats: Biochemical and histomorphometric evaluation of the ovary. Biochem Res Int 2013; 2013: 764262. [DOI:10.1155/2013/764262] [PMID] [PMCID]
16. Sibarani J, Tjahjodjati T, Atik N, Rachmadi D, Mustafa A. Urinary Cytochrome C and Caspase-3 as novel biomarker of renal function impairment in unilateral ureteropelvic junction obstruction model of wistar rats. Res Rep Urol 2020; 12: 217-224. [DOI:10.2147/RRU.S259237] [PMID] [PMCID]
17. Tham DM, Gardner CD, Haskell WL. Potential health benefits of dietary phytoestrogens: A review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 1998; 83: 2223-2235. https://doi.org/10.1210/jc.83.7.2223 [DOI:10.1210/jcem.83.7.4752] [PMID]
18. de Vere White RW, Tsodikov A, Stapp EC, Soares SE, Fujii H, Hackman RM. Effects of a high dose, aglycone-rich soy extract on prostate-specific antigen and serum isoflavone concentrations in men with localized prostate cancer. Nutr Cancer 2010; 62: 1036-1043. [DOI:10.1080/01635581.2010.492085] [PMID] [PMCID]
19. Sutrisno S, Gayatri M, Wiyasa IWA, Kalsum U, Andarini S. Genistein affects estrogen receptor alpha (ER-α)/estrogen receptor beta (ER-β) ratio, and nuclear factor-kappa beta (NF-κβ) in mice model of endometriosis. Bahrain Med Bull 2021; 43: 601-608.
20. Sutrisno S, Andarini S, Wiyasa IWA, Kulsum U, Noerhamdani N, Suyuti H, et al. The effect of implant origin differences on peritoneal endometriosis in an endometriosis mouse model. Int J Women's Healt Reprod Sci 2019; 7: 34-40. [DOI:10.15296/ijwhr.2019.06]
21. Puspitasari SC, Hendarto H, Widjiati W. [Effect of red dragon fruit skin extract (hylocereus polyrhizus) on interleukin-6 levels in endometriosis model mice.] J Biosains Pascasarj 2017; 19: 197-210. (in Indonesian) [DOI:10.20473/jbp.v19i3.2017.197-210]
22. Annas JY, Hendarto H, Widjiati W. [Efficacy of various doses of curcumin supplementation on progressive endometriosis in mice.] Maj Obstet Ginekol 2014; 22: 118-125. (in Indonesian)
23. Sutrisno S, Maharani M, Wahyuni ES. Effect of genistein on endometriosis lesion, matrix metalloproteinase-2 and -9 level of endometriosis: In silico and in vivo study. J Clin Mol Endocrinol 2016; 1: 4.
24. Sutrisno S, Wulandari RCL, Sulistyowati DWW, Wulandari RF, Wahyuni ES, Yueniwati Y, et al. Effect of genistein on proinflammatory cytokines and estrogen receptor-β in mice model of endometriosis. Asian Pacific J Reprod 2015; 4: 96-99. [DOI:10.1016/S2305-0500(15)30003-8]
25. Sutrisno S, Aprina H, Simanungkalit HM, Andriyani A, Barlianto W, Sujuti H, et al. Genistein modulates the estrogen receptor and suppresses angiogenesis and inflammation in the murine model of peritoneal endometriosis. J Tradit Complement Med 2018; 8: 278-281. [DOI:10.1016/j.jtcme.2017.03.002] [PMID] [PMCID]
26. Yang Zh, Kulkarni K, Zhu W, Hu M. Bioavailability and pharmacokinetics of genistein: Mechanistic studies on its ADME. Anticancer Agents Med Chem 2012; 12: 1264-1280. [DOI:10.2174/187152012803833107] [PMID] [PMCID]
27. Amreen S, Kumar P, Gupta P, Rao P. Evaluation of oxidative stress and severity of endometriosis. J Hum Reprod Sci 2019; 12: 40-46. [DOI:10.4103/jhrs.JHRS_27_17] [PMID] [PMCID]
28. Prieto L, Quesada JF, Cambero O, Pacheco A, Pellicer A, Codoceo R, et al. Analysis of follicular fluid and serum markers of oxidative stress in women with infertility related to endometriosis. Fertil Steril 2012; 98: 126-130. [DOI:10.1016/j.fertnstert.2012.03.052] [PMID]
29. Mulgund A, Doshi S, Agarwal A. The role of oxidative stress in endometriosis. In: Watson RR. Handbook of fertility: Nutrition, diet, lifestyle and reproductive health. Cambridge: Academic Press; 2015. [DOI:10.1016/B978-0-12-800872-0.00025-1]
30. Bina F, Soleymani S, Toliat T, Hajimahmoodi M, Tabarrai M, Abdollahi M, et al. Plant-derived medicines for treatment of endometriosis: A comprehensive review of molecular mechanisms. Pharmacol Res 2019; 139: 76-90. [DOI:10.1016/j.phrs.2018.11.008] [PMID]
31. Gołąbek A, Kowalska K, Olejnik A. Polyphenols as a diet therapy concept for endometriosis-current opinion and future perspectives. Nutrients 2021; 13: 1347. [DOI:10.3390/nu13041347] [PMID] [PMCID]
32. Harlev A, Gupta S, Agarwal A. Targeting oxidative stress to treat endometriosis. Exp Opin Ther Targets 2015; 19: 1447-1464. [DOI:10.1517/14728222.2015.1077226] [PMID]
33. Kim IS. Current perspectives on the beneficial effects of soybean isoflavones and their metabolites for humans. Antioxidants 2021; 10: 1064. [DOI:10.3390/antiox10071064] [PMID] [PMCID]
34. Chen W, Lin YC, Ma XY, Jiang ZY, Lan SP. High concentrations of genistein exhibit pro-oxidant effects in primary muscle cells through mechanisms involving 5-lipoxygenase-mediated production of reactive oxygen species. Food Chem Toxicol 2014; 67: 72-79. [DOI:10.1016/j.fct.2014.02.004] [PMID]
35. Singh P, Sharma S, Kumar Rath S. Genistein induces deleterious effects during its acute exposure in Swiss mice. Biomed Res Int 2014; 2014: 619617. [DOI:10.1155/2014/619617] [PMID] [PMCID]
36. Cai X, Liu M, Zhang B, Zhao S-J, Jiang S-W. Phytoestrogens for the management of endometriosis: Findings and issues. Pharmaceuticals 2021; 14: 569. [DOI:10.3390/ph14060569] [PMID] [PMCID]
37. Farruggio S, Raina G, Cocomazzi G, Librasi C, Mary D, Gentilli S, et al. Genistein improves viability, proliferation and mitochondrial function of cardiomyoblasts cultured in physiologic and peroxidative conditions. Int J Mol Med 2019; 44: 2298-2310. [DOI:10.3892/ijmm.2019.4365] [PMID]
38. Thangavel P, Puga-Olguín A, Rodríguez-Landa JF, Zepeda RC. Genistein as potential therapeutic candidate for menopausal symptoms and other related diseases. Molecules 2019; 24: 3892. [DOI:10.3390/molecules24213892] [PMID] [PMCID]
39. Gao Zh, Gao X, Fan W, Liu S, Li M, Miao Y, et al. Bisphenol A and genistein have opposite effects on adult chicken ovary by acting on ERα/Nrf2-Keap1-signaling pathway. Chem Biol Interact 2021; 347: 109616. [DOI:10.1016/j.cbi.2021.109616] [PMID]
40. Yuliawati D, Mintaroem K, Sutrisno S. Inhibitory effect of genistein on MMP-2 and MMP-9 expression through suppressing NF-κB activity in peritoneum of murine model of endometriosis. Asian Pacific J Reprod 2018; 7: 261-265. [DOI:10.4103/2305-0500.246344]
41. Ganai AA, Farooqi H. Bioactivity of genistein: A review of in vitro and in vivo studies. Biomed Pharmacother 2015; 76: 30-38. [DOI:10.1016/j.biopha.2015.10.026] [PMID]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb